Dr. Anna Groover is a Senior Scientist in the Translational Sciences group at BioMed Valley Discoveries, where she manages day-to-day clinical operations for clinical trials involving BVD-523, a selective, reversible, ERK1/2 inhibitor.
Anna joined BioMed Valley Discoveries after completing her PhD in anatomy and cell biology at the University of Kansas Medical Center. She received a BS degree in biology from Baylor University.
Current role
AI Scientist at Ekkel AI
Research Scientist at Mazumdar Shaw Medical Foundation (MSMF)
Research Resources Team Member at Australian Medical Students' Association
Data Science Vice President at PS AI Labs
ceo / Principal Scientist at Mecanica Scientific Services Corporation
Access the worlds's biggest network of public org charts
Learn more